Thus, while an insulin-based approach is the current standard of care for achieving glycemic control in hospitalized patients (3,12), concern about the risk of hypoglycemia, as well as potential cardiovascular risks, has led to a search of alternative treatment options, such as incretin-based therapy (13-15).